If You Invested $1,000 in Varex Imaging Corp (VREX)
This article examines the historical performance of investing $1,000 in Varex Imaging Corp (VREX) over various periods, including 1 year, 5 years, and since its trading inception in 2017. It details the company's business as a designer and manufacturer of X-ray imaging components for medical, industrial, and security markets, outlining its segments, global operations, and financial structure. The report also provides annual performance data for VREX and information about its strategic initiatives.
Price to sales forward of Varex Imaging Corporation – NASDAQ:VREX
The article provides a financial snapshot of Varex Imaging Corporation (NASDAQ: VREX) from TradingView, focusing on its price-to-sales forward metric. It appears to be a financial data page rather than a detailed analysis, offering various navigation and product links. The core content highlights the company's stock market presence and financial data availability.
Price to book forward of Varex Imaging Corporation – NASDAQ:VREX
This page from TradingView provides financial information for Varex Imaging Corporation (NASDAQ: VREX), specifically focusing on its price-to-book forward ratio. It includes links to various financial data, news, and community discussions related to the company, indicating it's a financial data service page rather than a detailed analytical article. The content is sparse, primarily serving as an entry point to more detailed financial metrics on the TradingView platform.
Varex Imaging Corporation becomes member of USACC
Varex Imaging Corporation has joined the United States-Azerbaijan Chamber of Commerce (USACC) as a new Regular Member. Varex Imaging is recognized globally for its advanced X-ray imaging technologies, providing cargo screening and security solutions for various missions worldwide. The company's expertise will contribute to USACC's growing network of industry leaders in an announcement made on USACC's X page.
Varex Imaging Corp (VREX) Technical Analysis: Support, Resistance, Indicators & Moving Averages
The technical analysis for Varex Imaging Corp (VREX) indicates a current price momentum score of 6.96, ranking it 127 out of 203 in the Healthcare Equipment & Supplies industry. The stock is trading between a resistance level of 11.39 and a support level of 9.44, suggesting suitability for range-bound swing trading. Both technical indicators (MACD, RSI, etc.) and moving averages (MA5 to MA200) predominantly signal "Sell," with 0 buy signals and 3 sell signals from indicators, and 0 buy signals and 6 sell signals from moving averages.
Varex Imaging Corp (VREX) Institutional Confidence
Varex Imaging Corp (VREX) currently holds an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. Institutional ownership stands at 103.49%, an increase of 6.87% quarter-over-quarter. Richard Pzena is the largest institutional shareholder, with 4.15 million shares, representing 9.52% of outstanding shares.
Varex Imaging Corp (VREX) Earnings Forecast: Future EPS & Revenue Growth Estimates
Varex Imaging Corp (VREX) currently has an earnings forecast score of 8.40 and a consensus price target of $18.00 from five analysts, indicating a 71.43% upside. The company's stock is rated a "Buy" by most analysts, with an expected revenue of $214.94 million for the next quarter and an anticipated EPS of $0.27.
How Varex Imaging Corporation (VREX) Affects Rotational Strategy Timing
This article analyzes Varex Imaging Corporation (VREX) using AI models to provide institutional trading strategies. It highlights a weak near-term sentiment but strong mid and long-term outlook, identifying an exceptional risk-reward setup. The analysis offers specific strategies for position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis.
Varex Imaging Corp (VREX) Valuation: PE, PB & Fair Value Analysis
The article provides a valuation analysis of Varex Imaging Corp (VREX), highlighting its current valuation score of 8.89, which ranks 53rd in the Healthcare Equipment & Supplies industry. It details the company's P/E ratio of -5.27, noting its deviation from recent highs and lows. The analysis also mentions that P/B, P/S, and P/CF relevant data have not yet been disclosed by the company.
Varex Imaging Corp (VREX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
The article provides a revenue breakdown for Varex Imaging Corp (VREX), detailing its regional revenue contributions. As of updated data on April 6th, financial figures for FY2026Q1, FY2025 (and its quarters), and FY2024 (and its quarters) have not yet been disclosed by the company. However, the available data shows revenue distribution by region, with APAC contributing the highest proportion at 33.35%, followed by the United States and EMEA.
Varex Imaging Corp (VREX) Financial Health: Profitability & Balance Sheet Analysis
Varex Imaging Corp (VREX) exhibits weak financial health with a score of 6.91, ranking 126 out of 203 in its industry, yet shows average operating efficiency. The company recently reported a 1.46% year-over-year revenue increase to $216.00M and a significant 217.39% year-over-year increase in net profit. However, details regarding cash and cash equivalents, total assets, liabilities, free cash flow, and other financial metrics have not yet been disclosed.
Wall Street Analysts See a 78.39% Upside in VAREX IMAGING (VREX): Can the Stock Really Move This High?
Wall Street analysts are forecasting a potential 78.4% upside for VAREX IMAGING (VREX), with a mean price target of $18. This optimism is further supported by positive earnings estimate revisions and a Zacks Rank #2 (Buy) rating. Despite the encouraging outlook, the article advises investors to approach price targets with skepticism, using them as a starting point for further research rather than the sole basis for investment decisions.
(VREX) and the Role of Price-Sensitive Allocations
This article analyzes Varex Imaging Corporation (NASDAQ: VREX) using AI models, indicating a near-term neutral sentiment but mid and long-term strength. It provides three distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles. The analysis highlights current price positioning signals and support/resistance levels across various time horizons.
Varex to Present at the Jefferies Global Healthcare Conference
Varex Imaging Corporation (Nasdaq: VREX) announced its management will present at the Jefferies Global Healthcare Conference in New York. The presentation will include a fireside chat on Wednesday, June 3, 2026, at 3:10 pm ET, and will be webcast live. Varex is a leading designer and manufacturer of X-ray imaging components for medical, industrial, and security applications.
VREX PE Ratio & Valuation, Is VREX Overvalued
Varex Imaging Corp (VREX) is currently considered undervalued, with a forward PE ratio of 10.89 compared to its five-year average of 20.29. Its fair price is estimated to be between $14.11 and $23.99, indicating it is undervalued by 28.07% relative to its current price of $10.15. Despite robust revenue growth, its P/S ratio of 0.46 is significantly above the industry average, which is deemed unsustainable.
VREX: Annual guidance, India ramp, photon counting, and AI drive growth and strategic flexibility
Varex Imaging Corporation (VREX) management has outlined stable growth supported by new annual guidance and three key drivers: expansion in India, cargo inspection, and photon counting technology. The company also highlights AI and digital infrastructure as crucial enablers, with recent debt refinancing providing strategic flexibility for future initiatives. This information is based on an audio transcript from the Jefferies Global Healthcare Conference 2026.
Varex to Present at the Jefferies Global Healthcare Conference
Varex Imaging Corporation announced it will present at the Jefferies Global Healthcare Conference in New York on Wednesday, June 3, 2026, at 3:10 PM ET. The presentation will be webcast and accessible via links provided by Business Wire and Varex's website. Varex is a leading innovator and manufacturer of X-ray imaging components for medical, industrial, and security applications.
How to watch Varex’s Jefferies healthcare fireside chat on June 3
Varex Imaging Corporation (Nasdaq: VREX) announced that its management will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 3, 2026, at 3:10 pm ET. The presentation will be webcast and accessible via Varex's website. Varex is a leading manufacturer of X-ray imaging components for medical, industrial, and security applications.
Varex to Present at the Jefferies Global Healthcare Conference
Varex Imaging Corporation announced that its management will present at the Jefferies Global Healthcare Conference on Wednesday, June 3, 2026, at 3:10 pm ET. The presentation will feature a fireside chat and will be webcast live. Varex is a leading manufacturer of X-ray imaging components used in medical, industrial, and security applications.
Varex to Present at the Jefferies Global Healthcare Conference
Varex Imaging Corporation (Nasdaq: VREX) announced its management will present at the Jefferies Global Healthcare Conference on Wednesday, June 3, 2026, at 3:10 pm ET. The presentation, a fireside chat, will be webcast live. Varex is a leading manufacturer of X-ray imaging components for medical, industrial, and security applications.
Responsive Playbooks and the VREX Inflection
This article provides an AI-driven analysis for Varex Imaging Corporation (NASDAQ: VREX), highlighting positive near-term sentiment within a long-term strength context, despite a weak mid-term bias. It outlines distinct trading strategies (Position, Momentum Breakout, Risk Hedging) with specific entry, target, and stop-loss zones, and presents a multi-timeframe signal analysis for VREX. The analysis also warns of elevated downside risk due to the absence of additional long-term support signals.
Compared to Estimates, VAREX IMAGING (VREX) Q2 Earnings: A Look at Key Metrics
VAREX IMAGING (VREX) reported Q2 2026 revenue of $216 million, a 1.5% year-over-year increase, but missed the Zacks Consensus Estimate of $217.2 million. The company's EPS of $0.21 also fell short of the $0.22 consensus estimate. Key performance metrics like Industrial Revenues, Medical Revenues, Industrial Gross Profit, and Medical Gross Profit showed mixed results compared to analyst estimates and year-ago figures.
Varex Imaging (VREX) Returns To Quarterly Profit And Tests Bearish Margin Narratives
Varex Imaging (VREX) reported a return to quarterly profit in Q1 2026 with a basic EPS of US$0.06, contrasting its trailing 12-month net loss of US$67.7 million. Despite modest 3.4% revenue growth, the company faces scrutiny over earning stability and interest coverage, fueling both bearish concerns about long-term earnings and bullish arguments pointing to a significant valuation gap and analyst price targets.
Varex Imaging Q2 Earnings Call Highlights
Varex Imaging reported solid fiscal second-quarter results with revenue within guidance, strong demand in medical and industrial segments, and completed debt refinancing. The company's medical revenue was boosted by CT strength, while industrial business saw solid demand in inspection applications. Varex is also investing in advanced imaging technologies and plans to reduce inventory and ramp up production in India, while providing full-year guidance for fiscal 2026.
Varex Imaging Corporation (NASDAQ:VREX) Q2 2026 Earnings Call Transcript
Varex Imaging Corporation reported its Q2 2026 earnings, with revenues of $216 million, non-GAAP gross margin of 34%, and non-GAAP EPS of $0.21, missing expectations slightly. The company saw solid performance in both Medical and Industrial segments, driven by CT sales and demand for nondestructive inspection applications, respectively. Varex also successfully refinanced its debt, strengthening its balance sheet, and provided annual revenue guidance of $860 million to $880 million and non-GAAP EPS of $0.80 to $1 for fiscal year 2026.
Varex Imaging Balances Margin Resilience With Slow Growth
Varex Imaging (VREX) reported Q2 revenue in line with guidance, showing a 1% year-over-year increase, alongside resilient non-GAAP margins and successful debt refinancing. Despite moderate growth and a GAAP loss, the company is investing in technology and manufacturing, with a focus on CT and photon-counting technologies and a new India manufacturing facility expected to improve margins. Varex reinstated annual guidance, signaling anticipated gradual improvement, though it acknowledges ongoing pressure from a sluggish market, higher operating expenses, and input cost inflation.
Varex Imaging (VREX) Q2 2026 Earnings Transcript
Varex Imaging (VREX) reported solid Q2 2026 results with total revenue up 1% to $216 million, driven by growth in both Medical and Industrial segments, and non-GAAP EPS of $0.21. The company successfully executed a debt refinancing, strengthening its capital structure and reducing interest expenses. Varex reinstated annual guidance, projecting full-year revenue of $860 million-$880 million and non-GAAP EPS of $0.80-$1.00, while continuing to invest in advanced imaging technologies and industrial applications, including photon counting and cargo security systems.
Varex outlines FY2026 revenue of $860M-$880M and non-GAAP EPS of $0.80-$1.00 while shifting to annual guidance
Varex Imaging Corporation has provided its financial guidance for fiscal year 2026, projecting revenues between $860 million and $880 million and non-GAAP EPS in the range of $0.80 to $1.00. This announcement marks a shift from quarterly to annual guidance, reflecting the company's expected recovery and growth, particularly in its Medical and Industrial segments. The company anticipates a gradual ramp-up in its X-ray detector business, especially with new product introductions and stabilizing inventory levels.
Varex Imaging Corporation 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:VREX)
Varex Imaging Corporation (NASDAQ:VREX) reported its Q2 2026 earnings, with an EPS of $0.21, which beat estimates, and revenue of $216.00M, missing expectations by $920K. The company published a slide deck in conjunction with its earnings call. This article provides access to the earnings summary, insights, and transcript for investors.
Varex Imaging Net Sales Rise to $226 Million in Second Quarter of Fiscal Year 2026
Varex Imaging Corporation announced its financial results for the second quarter of fiscal year 2026, reporting net sales of $226 million, an increase from $218 million in the prior year. Despite a slight decrease in gross margin from 30.8% to 30.3%, the company saw its net income rise to $16 million from $14 million. Operating expenses also increased to $53 million from $51 million.
Varex Announces Financial Results for Second Quarter Fiscal Year 2026
Varex Imaging Corporation announced its Q2 FY26 financial results, with revenues of $216 million, driven by solid demand in Medical and Industrial businesses. The company reported a GAAP net loss of $0.19 per diluted share and a non-GAAP net income of $0.21 per diluted share, with cash outflows from operations of $2 million. Varex expects revenue to be up approximately 3% in the second half of fiscal 2026, with full fiscal year 2026 revenue projected between $860 million and $880 million.
Varex Imaging (VREX) swings to Q2 loss, sets 2026 revenue and EPS guidance
Varex Imaging Corporation reported a Q2 fiscal 2026 revenue of $216 million, a 1% increase year-over-year, but still swung to a GAAP net loss of $0.19 per diluted share. Despite solid demand in both medical and industrial segments, lower margins and higher interest costs impacted profitability. The company expects full fiscal year 2026 revenue between $860 million and $880 million and non-GAAP EPS between $0.80 and $1.00.
Varex Q2 Revenue Rises 1%, Guides FY26 to $860M-$880M | VREX Stock News
Varex Imaging Corporation reported a 1% year-over-year revenue increase to $216 million in Q2 FY26, driven by solid demand in both Medical and Industrial segments. The company's cash and equivalents dropped to $88 million after debt refinancing. Varex anticipates revenue growth in the second half of fiscal 2026 and projects full-year fiscal 2026 revenue to be between $860 million and $880 million, with non-GAAP EPS between $0.80 and $1.00.
Precision Trading with Varex Imaging Corporation (VREX) Risk Zones
This article analyzes Varex Imaging Corporation (VREX), highlighting strong sentiment across all time horizons and an exceptional 59.7:1 risk-reward setup targeting a 15.6% gain against a 0.3% risk. It outlines three AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored for different risk profiles and holding periods, complete with entry zones, target prices, and stop losses. The analysis also provides multi-timeframe signal analysis, including support and resistance levels.
X-ray imaging maker Varex will post quarterly results after May 7 close
Varex Imaging Corporation (Nasdaq: VREX) announced it will report unaudited financial results for the second quarter of fiscal year 2026 after the close of regular trading on Thursday, May 7, 2026. A conference call will follow the earnings release at 3:00 pm Mountain Time, accessible via webcast on the company's website or by phone. The webcast and a replay will be available for investors.
Varex Schedules Second Quarter Fiscal Year 2026 Earnings Release and Conference Call
Varex Imaging Corporation announced it will release its unaudited financial results for the second quarter of fiscal year 2026 after market close on Thursday, May 7, 2026. This will be followed by a conference call at 3:00 pm Mountain Time the same day to discuss the results. The company provides details on how to access the webcast and conference call, along with replay information.
Varex Schedules Second Quarter Fiscal Year 2026 Earnings Release and Conference Call
Varex Imaging Corporation (Nasdaq: VREX) announced it will release its unaudited financial results for the second quarter of fiscal year 2026 after the market closes on Thursday, May 7, 2026. This will be followed by a conference call at 3:00 pm Mountain Time on the same day, which will be webcast live on the company's website. Investors can access the call via phone or find an archived replay on the website until May 21st.
Wall Street Analysts See a 57.62% Upside in VAREX IMAGING (VREX): Can the Stock Really Move This High?
Shares of VAREX IMAGING (VREX) have seen a 2.5% gain, closing at $11.42, with Wall Street analysts projecting a potential upside of 57.6% based on a mean price target of $18. This optimism is further supported by a positive trend in earnings estimate revisions and a Zacks Rank #1 (Strong Buy) rating. While price targets should be treated with skepticism due to potential analyst biases, the consistent upward revision of earnings estimates suggests genuine potential for stock appreciation.
Technical Reactions to VREX Trends in Macro Strategies
This article analyzes Varex Imaging Corporation (NASDAQ: VREX) using AI models, identifying near-term strong sentiment transitioning to mid-term neutrality and long-term positive bias. It highlights elevated downside risk due to a lack of long-term support signals. The analysis provides three distinct institutional trading strategies, including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis.
Varex Imaging to redeem $368 million of 7.875% senior secured notes due 2027
Varex Imaging Corporation has announced its intention to redeem $368 million of its outstanding 7.875% Senior Secured Notes due 2027. The redemption is expected to take place on May 15, 2026, at a price of 103.938% of the principal amount, plus accrued and unpaid interest. This move aims to optimize the company's capital structure.
How many employees work at Varex Imaging?
Varex Imaging Corp. currently has 2,116 employees, according to Revelio Labs data, showing a year-over-year growth rate of 5.4%. The company, a leading independent supplier of medical X-ray tubes and image processing solutions, had 2,115 employees in 2025, an increase from 2,004 in 2024 and 2,020 in 2023. Revelio Labs also reports Varex Imaging's average salary at $75.7k, tenure at 4.9 years, and 63 active job postings in 2025.
JPMorgan Chase & Co. Acquires 225,238 Shares of Varex Imaging $VREX
JPMorgan Chase & Co. significantly increased its stake in Varex Imaging (NASDAQ:VREX) by 381.8% in the third quarter, acquiring an additional 225,238 shares to own a total of 284,227 shares valued at approximately $3.52 million. This move makes JPMorgan Chase & Co. a 0.68% shareholder in the company. The article also notes mixed analyst ratings for Varex, with a consensus "Hold" rating and a $16.17 average target price, following the company's Q1 earnings beat and Q2 2026 guidance.
VREX Stock News Today | Earnings, Events & Price Alerts
This article provides recent news and event updates for Varex Imaging (VREX), including a new credit agreement, investor conference presentations, and senior secured notes redemption. Key financial announcements detail Q1 2026 revenue exceeding expectations at $210 million, driven by strength in cargo systems, and a Q2 revenue outlook of $210M to $225M. Analyst predictions also suggest a potential 29.92% rise for VREX.
VREX Technical Analysis & Stock Price Forecast
This article provides a technical analysis and stock price forecast for Varex Imaging Corp (VREX), indicating a "Strong Sell" consensus based on various technical indicators. The analysis covers moving averages, momentum indicators like RSI and MACD, and identifies key support and resistance levels. The stock is currently trading below its 200-day moving average, reinforcing the bearish sentiment.
Trading the Move, Not the Narrative: (VREX) Edition
This article provides an AI-generated analysis for Varex Imaging Corporation (NASDAQ: VREX), highlighting divergent sentiment across different time horizons and suggesting choppy conditions. It presents three distinct trading strategies (Position, Momentum Breakout, Risk Hedging) tailored to various risk profiles, along with multi-timeframe signal analysis indicating support and resistance levels. The report emphasizes trading the move rather than the narrative, leveraging institutional-grade predictive AI.
VREX SEC Filings - Varex Imaging Corp 10-K, 10-Q, 8-K Forms
This page provides a comprehensive overview of Varex Imaging Corp (VREX) SEC filings, including 10-K annual reports, 10-Q quarterly reports, and 8-K material event forms. It details recent filings such as a 10-Q quarterly earnings report, Pzena Investment's increased ownership to over 10%, and a director's stock sale. The platform offers AI-powered summaries to help investors quickly grasp key information from these regulatory documents.
Varex Imaging (VREX) SVP Jesse Merkley reports shares, RSUs, PSUs and options
Varex Imaging Corp's SVP and GM, Industrial, Jesse Don Merkley, filed an initial ownership report detailing his equity holdings in the company. The report indicates he directly holds 15,334 shares of common stock, alongside various equity awards including restricted stock units (RSUs), performance stock units (PSUs), and a non-qualified stock option for 9,727 shares. These awards are subject to vesting schedules and performance conditions, demonstrating a comprehensive equity compensation structure for the executive.
Varex Imaging Corp (NASDAQ: VREX) — Vanguard files amendment showing 0% ownership
The Vanguard Group filed an amended Schedule 13G/A for Varex Imaging Corp (VREX), reporting 0 shares beneficially owned, representing 0% of the class. This amendment follows an internal realignment at Vanguard effective January 12, 2026, which prompted subsidiaries to report their holdings separately. The filing confirms that The Vanguard Group itself no longer retains beneficial ownership over these securities, with future filings expected from disaggregated entities.
Varex Imaging (VREX) SVP Garcia details stock, RSU and option holdings
Varex Imaging Corp's Senior Vice President of Regulatory and Quality Assurance, Victor Hugo Garcia, filed a Form 3 detailing his equity holdings in the company. The filing indicates direct ownership of 23,360 shares of common stock, in addition to various restricted stock units, performance stock units, and non-qualified stock options. These holdings represent Garcia's existing stake and not new open-market transactions.
Varex Imaging (VREX) director sells 4,510 shares, keeps 23,450
Varex Imaging Corp director Jay K. Kunkel sold 4,510 shares of common stock at $11.14 per share in an open-market transaction on March 20, 2026. Following this sale, Kunkel directly holds 23,450 shares, maintaining a significant equity stake in the company. The transaction was filed as a Form 4 with the SEC.
